>
South Africa carries one of the world's most complex disease burdens — simultaneously managing the largest HIV epidemic globally, the highest TB incidence per capita, a rising tide of non-communicable diseases, and pervasive injury from violence and road traffic crashes. This skill provides the epidemiological frameworks, SA-specific disease data, PHC system architecture, and health metric knowledge required for a fractional Healthcare Director operating at district, regional, or national level.
All outputs support qualified public health practitioners and health managers. Clinical recommendations require qualified medical or public health officer review. Epidemiological figures carry uncertainty intervals — treat point estimates as references, not absolutes.
| Measure | Definition | Formula | Typical Use |
|---|---|---|---|
| Prevalence | Proportion of population with condition at a point in time | Cases / Population at risk | Chronic diseases, HIV, HTN |
| Incidence rate | New cases per population per time unit | New cases / Person-time at risk | TB notification rate, cholera outbreaks |
| Cumulative incidence | Proportion developing condition over period | New cases / Population at risk (start) | Vaccine trial endpoints |
| Attack rate | Cumulative incidence in outbreak setting | Cases / Exposed population | Foodborne outbreak, measles cluster |
| Case Fatality Rate (CFR) | Proportion of cases that die | Deaths / Confirmed cases | Ebola, COVID-19 severity tracking |
| Infection Fatality Rate (IFR) | Deaths / All infected (including undiagnosed) | Deaths / Estimated all infections | Harder to measure; requires seroprevalence data |
Prevalence vs Incidence relationship:
Prevalence ≈ Incidence Rate × Average Duration of Disease
A high prevalence can reflect either high incidence OR long disease duration (or both). HIV has both high incidence and long duration with ART — hence 7.8M PLHIV despite decades of epidemic.
SA context: The Western Cape has an older age profile than Limpopo. Crude mortality comparisons will systematically understate mortality burden in younger provinces if not age-adjusted.
| Curve Type | Shape | Implication | SA Example |
|---|---|---|---|
| Common-source (point) | Sharp peak, rapid decline | Single exposure event | Listeriosis outbreak 2017–2018 (polony) |
| Common-source (continuous) | Sustained plateau | Ongoing exposure source | Contaminated water supply |
| Propagated (person-to-person) | Multiple successive waves, each larger | Human-to-human transmission | Measles, COVID-19 waves |
| Mixed | Initial sharp peak + propagated tail | Index case triggers secondary spread | Ebola nosocomial + community spread |
| Pathogen | Approximate R0 | Implications |
|---|---|---|
| Measles | 12–18 | Requires ~94% population immunity to halt transmission |
| COVID-19 (original strain) | 2–3 | Herd immunity threshold ~50–67% |
| TB (Mtb) | 1–2 (slow) | Long infectious period sustains transmission at low R0 |
| HIV | 2–5 (without interventions) | R0 depends heavily on behaviour and viral load |
Selection bias: Non-random selection into study or surveillance system.
Information bias: Systematic error in measuring exposure or outcome.
Confounding: Third variable associated with both exposure and outcome.
Controlling confounding: Stratification, multivariate regression, matching, restriction. In SA public health, age, sex, HIV status, and geography are near-universal confounders.
South Africa is uniquely challenged by simultaneous epidemics across four categories, with social determinants (poverty, inequality, unemployment, housing) driving all four.
| Indicator | Value (2023/2024 estimates) | Source |
|---|---|---|
| People living with HIV (PLHIV) | ~7.8 million | HSRC/SANAC |
| Adult (15–49) HIV prevalence | ~19% | HSRC 2022 Household Survey |
| New infections per year | ~170,000–200,000 | UNAIDS |
| People on ART | ~5.9 million | NDOH ART statistics |
| HIV+ pregnant women on PMTCT | >95% | DHIS2 |
| Mother-to-child transmission rate | ~1.4% (at 10 weeks) | NDOH |
SA has the largest ART programme in the world. The 90-90-90 UNAIDS targets (now updated to 95-95-95):
SA performance (2023): approximately 94-78-88. The second 95 (ART coverage) remains the key gap — people who test positive but do not link to or remain in care.
Key programmatic terms:
| Indicator | Value | Context |
|---|---|---|
| TB incidence rate | ~520/100,000 population | Highest in world per capita (WHO 2023) |
| New TB cases notified annually | ~270,000–300,000 | NDOH |
| TB/HIV co-infection | ~50–60% of new TB cases | A defining feature of SA epidemic |
| MDR-TB cases | ~8,000–9,000/year | Drug-resistant burden is significant |
| XDR-TB | ~450–600/year | Extensively drug-resistant; limited treatment options |
| TB treatment success rate (DS-TB) | ~82–85% | Below 90% WHO target |
Drug-resistant TB definitions:
| Category | Resistance Profile |
|---|---|
| DS-TB (Drug-susceptible) | Sensitive to rifampicin and isoniazid |
| RR-TB (Rifampicin-resistant) | Resistant to rifampicin (most important first-line drug) |
| MDR-TB | Resistant to at least rifampicin + isoniazid |
| Pre-XDR-TB | MDR + resistant to any fluoroquinolone |
| XDR-TB | Pre-XDR + resistant to at least one Group A drug (bedaquiline or linezolid) |
SA TB programme architecture:
| NCD | Prevalence (Adults) | Key Drivers | SA Programme |
|---|---|---|---|
| Hypertension | ~48% of adults (SANHANES) | Obesity, salt, stress, alcohol | Chronic Disease Management (CDM) at PHC level |
| Diabetes (Type 2) | ~13% of adults | Obesity, diet, sedentary lifestyle | CDM, foot care clinics |
| Cardiovascular disease | Leading cause of death in 35–64 age group | HTN, diabetes, smoking, dyslipidaemia | Risk factor screening at PHC |
| Cancer | ~100,000 new cases/year (NCRSA) | Cervical (HPV), breast, prostate, lung, oesophageal | NHLS pathology, oncology referral pathway |
| Chronic Respiratory Disease | ~COPD, asthma underdiagnosed | Occupational exposure (mining), tobacco, TB sequelae | PHC spirometry pilot sites |
| Obesity | ~68% of adult women overweight/obese | Urbanisation, ultra-processed foods | HEALA advocacy, food labelling regulations |
NCD double burden in SA: NCDs and communicable diseases are not competing — they are synergistic. HIV accelerates cardiovascular disease; TB causes lung destruction; poverty drives both.
| Injury Category | SA Rate | Benchmark |
|---|---|---|
| Interpersonal violence (homicide) | ~45/100,000 (one of highest globally) | Global average ~6/100,000 |
| Road traffic deaths | ~25.9/100,000 | More than double WHO target |
| Femicide | ~5× global average | GBV crisis declared national emergency |
| Drowning | High paediatric burden | Unguarded pools, rivers |
Injuries are the leading cause of death in 15–44 year age group in SA — YLLs (Years of Life Lost) are disproportionate to absolute numbers.
Disability-Adjusted Life Year (DALY) = Years of Life Lost (YLL) + Years Lived with Disability (YLD)
SA leading causes of DALYs (IHME/SAMRC data):
PHC re-engineering is the NDoH's strategy to shift SA from a hospital-centric to a community-based health system. Three streams:
Stream 1 — Ward-Based Outreach Teams (WBOTs)
Stream 2 — School Health Teams
Stream 3 — District Clinical Specialist Teams (DCSTs)
National Department of Health (NDoH)
↓
Provincial Department of Health (9 provinces)
↓
District Health System (~52 health districts)
↓
Sub-district / Local Municipality
↓
Community Health Centre (CHC) — 24hr facility
↓
Fixed Clinic / Satellite Clinic
↓
Mobile Clinic / WBOT / Community Health Worker
The District Health System (DHS) is the operational unit of PHC delivery:
The Ideal Clinic Realisation and Maintenance (ICRM) programme assesses clinics against a set of standards across 10 components:
| Component | Examples |
|---|---|
| Administration | Clinic committee, pharmacy stock, personnel lists |
| Human Resources | Staff ratios, leave management |
| Finance | Budget management, petty cash |
| Facility/Infrastructure | Maintenance, HVAC, waiting areas |
| Medicine and Supplies | Essential Medicines List compliance, cold chain |
| Equipment | Calibration records, service schedules |
| Connectivity/IT | HPRS/DHIS2, computer infrastructure |
| Quality of Care | Clinical protocols, adverse event reporting |
| Infection Prevention & Control (IPC) | Hand hygiene, PPE, waste management |
| Community Interface | Health committees, outreach |
Status rating: Ideal, Silver, Gold, or suboptimal. Target: all clinics to attain Ideal status.
The NICD (part of NHLS) is SA's national public health institute for communicable disease intelligence:
The Notifiable Medical Conditions Regulations (R. 883 of 2017) list 47 conditions requiring mandatory reporting to the DoH. Health professionals, laboratories, and facilities all have reporting obligations.
Category 1 — Immediate notification (within 24 hours):
| Condition | Notes |
|---|---|
| Anthrax | Bioterrorism risk |
| Botulism | |
| Cholera | |
| Diphtheria | |
| Ebola | Viral haemorrhagic fever |
| Human influenza (novel subtype) | Pandemic potential |
| Meningococcal meningitis/septicaemia | |
| Plague | |
| Rabies | |
| Severe Acute Respiratory Syndrome (SARS) | |
| Smallpox | |
| Viral haemorrhagic fevers (Marburg, Lassa, Crimean-Congo) | |
| Yellow fever |
Category 2 — Within 5 days: Includes TB (all forms), HIV (newly diagnosed), typhoid, measles, rubella, pertussis, tetanus, polio, malaria, brucellosis, food poisoning, Hepatitis A/B/C/E, listeriosis, leptospirosis, typhus, and others.
Reporting pathway:
Clinician/Lab → District Disease Surveillance Officer
→ Provincial Health Department
→ NDoH Epidemiology cluster
→ WHO (for IHR-notifiable conditions)
| Type | Description | SA Examples |
|---|---|---|
| Mandatory/Passive | All cases must be reported | NMC list — TB, cholera, measles |
| Sentinel/Active | Selected sites report all cases (more complete but limited sites) | Influenza (SARI) sentinels, maternal mortality (NCCEMD) |
| Syndromic | Report clinical syndrome without waiting for lab confirmation | ILI/SARI — faster signal for emerging threats |
DATIM is the PEPFAR-mandated data system for HIV/AIDS programme monitoring:
The NHI Act establishes a single-payer national health insurance system. Core architecture:
| Element | Detail |
|---|---|
| Fund structure | Single NHI Fund — public entity, governed by Board |
| Purchasing model | Monopsony purchaser of healthcare services |
| Provider contracting | Both public and private providers accredited and contracted |
| Benefit package | Defined by Advisory Committees — comprehensive PHC + essential hospital |
| Financing | General tax revenue + payroll levy (Fiscus contribution) |
| Medical schemes | Role significantly curtailed — cannot cover services covered by NHI |
Constitutional challenge status (as of 2024–2025): Multiple legal challenges lodged by DA, SAMA, BHF. ConCourt challenge on medical scheme provisions anticipated. Implementation is phased — full NHI fund functionality is a multi-year horizon.
| Phase | Period | Key Milestones |
|---|---|---|
| Phase 1 (complete) | 2012–2017 | Pilots in 10 districts, Ideal Clinic programme |
| Phase 2 (underway) | 2017–2022 | GP contracting pilots (CUPs), health system strengthening |
| Phase 3 (in progress) | 2023+ | NHI Fund establishment, provider accreditation framework |
| Full implementation | 2030+ (est.) | Subject to fiscal envelope and legal resolution |
CUPs are the geographic unit for PHC contracting under NHI:
Under NHI, the PHC benefit package is intended to be comprehensive:
Reference price setting for NHI services is done by the Office of Health Products and Technologies (OHPT) — previously the Pricing Committee.
The WHO Ottawa Charter remains the foundational framework for health promotion globally and is explicitly referenced in SA health policy:
| Action Area | SA Application |
|---|---|
| Build healthy public policy | Tobacco Products and Electronic Delivery Systems Act, sugar tax (Health Promotion Levy), food labelling regulations |
| Create supportive environments | Safe urban design, school nutrition, housing programmes |
| Strengthen community action | WBOTs, ward-based health committees, Community Health Workers |
| Develop personal skills | Health literacy programmes, lifeskills in schools |
| Reorient health services | PHC re-engineering, wellness screening at workplaces |
UPSTREAM (Structural/Social determinants)
Poverty reduction, housing, education, employment
Clean water and sanitation (Blue Drop/Green Drop)
Food security programmes (SNAP, school nutrition)
↓
MIDSTREAM (Community/Behavioural)
WBOT health promotion visits
Community support groups (PLHIV, TB, DM)
School health education
↓
DOWNSTREAM (Individual/Clinical)
ART, TB treatment, chronic disease medication
Surgical interventions
Hospital-based care
Health promotion theory holds that downstream interventions are necessary but insufficient — upstream structural change is required for sustained population health improvement. SA's quadruple burden is largely an upstream failure (apartheid spatial planning, inequality, poverty).
Tobacco control:
Substance abuse:
Gender-based violence:
Obesity and NCDs:
| Indicator | SA Value | Comparators |
|---|---|---|
| Life expectancy at birth (overall) | ~64.6 years (2023 est.) | Sub-Saharan Africa avg ~61; Global avg ~73 |
| Life expectancy — female | ~68 years | |
| Life expectancy — male | ~61 years | |
| Under-5 mortality rate (U5MR) | ~34/1,000 live births | MDG5 target achieved; SDG target <25 |
| Infant mortality rate (IMR) | ~25/1,000 live births | Neonatal deaths (first 28 days) drive IMR |
| Neonatal mortality rate (NMR) | ~12/1,000 live births | Prematurity, birth asphyxia, infections |
| Maternal mortality ratio (MMR) | ~119/100,000 live births | NCCEMD Triennial Report; target <70 |
| Stillbirth rate | ~22/1,000 births | High compared to income peers |
Maternal mortality leading causes in SA (NCCEMD data):
The NCCEMD (National Committee on Confidential Enquiries into Maternal Deaths) produces triennial "Saving Mothers" reports — essential reference for district maternal health management.
The Expanded Programme on Immunisation (EPI) schedule for SA:
| Age | Vaccines |
|---|---|
| Birth | BCG, OPV 0 (birth dose) |
| 6 weeks | DTaP-IPV-Hib-HepB (hexavalent), PCV13, RV1 (rotavirus) |
| 10 weeks | DTaP-IPV-Hib-HepB, PCV13 |
| 14 weeks | DTaP-IPV-Hib-HepB, PCV13, RV1 |
| 6 months | MenAfriVac (meningococcal A — northern border areas) |
| 9 months | Measles 1, MenAfriVac |
| 12 months | PCV13 (booster) |
| 18 months | Measles 2, DTaP-IPV booster |
| 6 years (Grade R) | Td (tetanus-diphtheria) |
| 9 years (Grade 4) | HPV1 (Cervarix — girls only; NDOH piloting gender-neutral) |
| 10 years (Grade 5) | HPV2 |
Coverage targets: WHO recommends ≥95% coverage for all antigens. SA DTP3 coverage is ~90–93% nationally but with significant subnational variation (rural districts lower).
Cold chain: 2–8°C for most vaccines; BCG and MMR cannot be frozen. Cold chain failures are a quality-of-care indicator monitored under Ideal Clinic.
| Metric | SA Performance | Target |
|---|---|---|
| TB case detection rate | ~76% (estimated vs notified) | 90% |
| Treatment success rate (DS-TB) | ~82–85% | 90% |
| MDR-TB treatment success | ~55–65% | 75% |
| TB preventive therapy (TPT) coverage in PLHIV | ~78% | 90% |
| Contact screening completion | Variable (~40–70% district-dependent) | 90% |
| Indicator | SA Value |
|---|---|
| ANC 1st visit before 20 weeks | ~78% |
| ANC 4+ visits | ~91% |
| Facility delivery | ~97% |
| Postnatal care within 6 days | ~88% |
High facility delivery rate is an SA strength — institutional deliveries reduce perinatal mortality. Challenge is quality of care at delivery, not access.
/health/SKILL.md — parent domain manifest/health/clinical/SKILL.md — clinical systems complement